MR Montage Resources Corporation

Leading Chinese medical devices maker Mindray Medical International Limited (MR) recently announced that it will feature new upgrades to its hand-held M Series ultrasound platforms at the ongoing American Society of Anesthesiologists (“ASA”) meeting in Chicago. The company will showcase enhancements to its M7 and M5 ultrasound systems at the ASA meet.

Mindray launched the M7 ultrasound system in the U.S. in August 2010. This novel system leverages the company’s high-performance “System On Chip (SOC)” technology enabling a high level of imaging capability to a portable system.

This higher-end segment of the ultrasound business is experiencing tremendous growth as more and more healthcare providers acquire sophisticated capabilities in compact and portable form. Mindray hopes to capitalize on this shift in hospital purchasing behavior with its M7 offering, which combine value and quality features, not always found in portable machines.

As part of the enhancements to the M7 system, Mindray will introduce, at the ASA meet, a new needle visualization technology dubbed “iNeedle,” which enables clear needle detection during procedures. The company will also launch new transducers (devices that convert energy into ultrasonic sound waves) at the meeting.  Besides the M7, Mindray will also feature its coveted M5 ultrasound system at the ASA.

Mindray remains committed to providing clinicians with the latest technology that enhances patient care. The company believes that its progress, with the M7 and M5 systems, demonstrates its keenness to impart diagnostic confidence to clinicians using the company’s products. Its state-of-the-art ultrasound systems are enjoying significant traction in North America.

With its operational headquarters in Shenzhen, China, Mindray is a global Chinese medical devices company. Besides China, the company operates in North America, Europe and other Asian countries. 

Mindray has a strong position in the low and mid segments of the medical devices market in China and is poised to benefit from the solid fundamentals of the Chinese health care sector. Mindray competes with global devices manufacturers such as General Electric (GE), Philips (PHG) and Siemens (SI). We are currently Neutral on the stock.

 
GENL ELECTRIC (GE): Free Stock Analysis Report
 
MINDRAY MEDICAL (MR): Free Stock Analysis Report
 
KONINKLIJKE PHL (PHG): Free Stock Analysis Report
 
SIEMENS AG-ADR (SI): Free Stock Analysis Report
 
Zacks Investment Research